{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:45:32Z","timestamp":1792691132872,"version":"4.5.0"},"reference-count":272,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004329","name":"Javna Agencija za Raziskovalno Dejavnost RS","doi-asserted-by":"publisher","award":["P2-0249"],"award-info":[{"award-number":["P2-0249"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004329","name":"Javna Agencija za Raziskovalno Dejavnost RS","doi-asserted-by":"publisher","award":["P3-0003"],"award-info":[{"award-number":["P3-0003"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1053\/j.seminoncol.2019.04.002","type":"journal-article","created":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T18:18:48Z","timestamp":1557425928000},"page":"173-191","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":108,"title":["Electrochemotherapy of superficial tumors \u2013 Current status:"],"prefix":"10.1053","volume":"46","author":[{"given":"Luca G.","family":"Campana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3506-9449","authenticated-orcid":false,"given":"Damijan","family":"Miklav\u010di\u010d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2840-5184","authenticated-orcid":false,"given":"Giulia","family":"Bertino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Marconato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Valpione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Imarisio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3967-9861","authenticated-orcid":false,"given":"Maria Vittoria","family":"Dieci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Granziera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1418-1928","authenticated-orcid":false,"given":"Maja","family":"Cemazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Alaibac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7641-5670","authenticated-orcid":false,"given":"Gregor","family":"Sersa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminoncol.2019.04.002_bib0001","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/nrc.2017.93","article-title":"Transport of drugs from blood vessels to tumour tissue","volume":"17","author":"Dewhirst","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0002","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nrc1893","article-title":"Drug penetration in solid tumours","volume":"6","author":"Minchinton","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0003","doi-asserted-by":"crossref","DOI":"10.1063\/1.4949264","article-title":"Tutorial: Electroporation of cells in complex materials and tissue","volume":"119","author":"Rems","year":"2016","journal-title":"J Appl Phys"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0004","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ejso.2007.05.016","article-title":"Electrochemotherapy in treatment of tumours","volume":"34","author":"Sersa","year":"2008","journal-title":"Eur J Surg Oncol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0005","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00008390-200502000-00008","article-title":"Treatment of metastatic melanoma using electroporation therapy with bleomycin (electrochemotherapy)","volume":"15","author":"Byrne","year":"2005","journal-title":"Melanoma Res"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0006","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/00008390-200010000-00009","article-title":"Electrochemotherapy of cutaneous metastases in malignant melanoma","volume":"10","author":"Rols","year":"2000","journal-title":"Melanoma Res"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0007","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/01.sla.0000250419.36053.33","article-title":"Electrochemotherapy: aspects of preclinical development and early clinical experience","volume":"245","author":"Larkin","year":"2007","journal-title":"Ann Surg"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0008","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejcsup.2006.08.003","article-title":"Standard operating procedures of the electrochemotherapy: Instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the Cliniporator by means of invasive or non-invasive electrodes","volume":"4","author":"Mir","year":"2006","journal-title":"Eur J Cancer Suppl"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0009","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1200\/JCO.2014.55.4634","article-title":"Efficacy of skin-directed therapy for cutaneous metastases from advanced cancer: a meta-analysis","volume":"32","author":"Spratt","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0010","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ejso.2012.08.016","article-title":"Antitumor effectiveness of electrochemotherapy: a systematic review and meta-analysis","volume":"39","author":"Mali","year":"2013","journal-title":"Eur J Surg Oncol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0011","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1016\/j.ejso.2016.06.399","article-title":"Treatment efficacy with electrochemotherapy: a multi-institutional prospective observational study on 376 patients with superficial tumors","volume":"42","author":"Campana","year":"2016","journal-title":"Eur J Surg Oncol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0012","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejcsup.2006.08.002","article-title":"Electrochemotherapy \u2013 an easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study","volume":"4","author":"Marty","year":"2006","journal-title":"Eur J Cancer Suppl"},{"issue":"Suppl 3","key":"10.1053\/j.seminoncol.2019.04.002_bib0013","doi-asserted-by":"crossref","first-page":"I1","DOI":"10.1186\/1475-925X-14-S3-I1","article-title":"Electrochemotherapy (ECT) and irreversible electroporation (IRE) \u2013 advanced techniques for treating deep-seated tumors based on electroporation","volume":"14","author":"Miklavcic","year":"2015","journal-title":"Biomed Eng Online"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0014","doi-asserted-by":"crossref","first-page":"E727","DOI":"10.1055\/a-0590-4053","article-title":"Endoscopic electrochemotherapy for esophageal cancer: a phase I clinical study","volume":"6","author":"Egeland","year":"2018","journal-title":"Endoscopy Int Open"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0015","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/j.1460-2075.1982.tb01257.x","article-title":"Gene transfer into mouse lyoma cells by electroporation in high electric fields","volume":"1","author":"Neumann","year":"1982","journal-title":"EMBO J"},{"issue":"3","key":"10.1053\/j.seminoncol.2019.04.002_bib0016","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.bbagen.2005.05.006","article-title":"Mechanisms of cell membrane electropermeabilization: a minireview of our present (lack of ?) knowledge","volume":"1724","author":"Teissie","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0017","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1749-6632.1994.tb30442.x","article-title":"Molecular basis for cell membrane electroporation","volume":"720","author":"Weaver","year":"1994","journal-title":"Ann N Y Acad Sci"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0018","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11517-005-0020-2","article-title":"Membrane electroporation theories: a review","volume":"44","author":"Chen","year":"2006","journal-title":"Med Biol Eng Comput"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0019","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1016\/j.bbamem.2016.03.022","article-title":"A molecular insight into the electro-transfer of small molecules through electropores driven by electric fields","volume":"1858","author":"Casciola","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0020","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.bioelechem.2016.03.005","article-title":"Properties of lipid electropores II: comparison of continuum-level modeling of pore conductance to molecular dynamics simulations","volume":"112","author":"Rems","year":"2016","journal-title":"Bioelectrochemistry"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0021","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13628-018-0044-2","article-title":"Transport of charged small molecules after electropermeabilization - Drift and diffusion","volume":"11","author":"Sozer","year":"2018","journal-title":"BMC Biophys"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0022","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.bioelechem.2017.09.005","article-title":"Investigation of the chemical mechanisms involved in the electropulsation of membranes at the molecular level","volume":"119","author":"Breton","year":"2018","journal-title":"Bioelectrochemistry"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0023","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jconrel.2018.07.021","article-title":"Connecting the in vitro and in vivo experiments in electrochemotherapy \u2013 A feasibility study modeling cisplatin transport in mouse melanoma using the dual-porosity model","volume":"286","author":"Dermol-Cerne","year":"2018","journal-title":"J Control Release"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0024","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0005-2736(94)90045-0","article-title":"Electropermeabilization of cells in tissues assessed by the qualitative and quantitative electroloading of bleomycin","volume":"1190","author":"Belehradek","year":"1994","journal-title":"Biochim Biophys Acta"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0025","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.1002\/1097-0142(19931215)72:12<3694::AID-CNCR2820721222>3.0.CO;2-2","article-title":"Electrochemotherapy, a new antitumor treatment. First clinical phase I-II trial","volume":"72","author":"Belehradek","year":"1993","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0026","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1046\/j.1365-201X.2003.01093.x","article-title":"Electroporation. theory and methods, perspectives for drug delivery, gene therapy and research","volume":"177","author":"Gehl","year":"2003","journal-title":"Acta Physiol Scand"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0027","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1089\/hum.2005.16.1194","article-title":"Electrophoretic component of electric pulses determines the efficacy of in vivo DNA electrotransfer","volume":"16","author":"Satkauskas","year":"2005","journal-title":"Hum Gene Ther"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0028","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2174\/1566523216666160331130040","article-title":"Gene electrotransfer: a mechanistic perspective","volume":"16","author":"Rosazza","year":"2016","journal-title":"Curr Gene Ther"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0029","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1517\/14712598.2016.1098615","article-title":"Gene transfer by pulsed electric field is highly promising in cutaneous wound healing","volume":"16","author":"Gibot","year":"2016","journal-title":"Expert Opin Biol Ther"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124913","article-title":"Gene Electrotransfer of plasmid with tissue specific promoter encoding shrna against endoglin exerts antitumor efficacy against murine TS\/A tumors by vascular targeted effects","volume":"10","author":"Stimac","year":"2015","journal-title":"PloS One"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0031","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/978-1-4614-9632-8_21","article-title":"Gene electrotransfer in clinical trials","volume":"1121","author":"Gehl","year":"2014","journal-title":"Methods Mol Biol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0032","doi-asserted-by":"crossref","first-page":"5896","DOI":"10.1200\/JCO.2007.15.6794","article-title":"Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma","volume":"26","author":"Daud","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0033","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10555-016-9615-3","article-title":"The promising alliance of anti-cancer electrochemotherapy with immunotherapy","volume":"35","author":"Calvet","year":"2016","journal-title":"Cancer Metastasis Rev"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0034","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/nrg2432","article-title":"DNA vaccines: ready for prime time?","volume":"9","author":"Kutzler","year":"2008","journal-title":"Nat Rev Genet"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0035","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1517\/17425247.2016.1121990","article-title":"Clinical potential of electroporation for gene therapy and DNA vaccine delivery","volume":"13","author":"Lambricht","year":"2016","journal-title":"Exp Opin Drug Deliv"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0036","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1016\/S0140-6736(15)00239-1","article-title":"Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2\/3: a randomised, double-blind, placebo-controlled phase 2b trial","volume":"386","author":"Trimble","year":"2015","journal-title":"Lancet"},{"issue":"1","key":"10.1053\/j.seminoncol.2019.04.002_bib0037","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1109\/TBME.2014.2367543","article-title":"A review of basic to clinical studies of irreversible electroporation therapy","volume":"62","author":"Jiang","year":"2015","journal-title":"IEEE Trans Biomed Eng"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0038","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jvir.2014.01.028","article-title":"Irreversible electroporation for nonthermal tumor ablation in the clinical setting: a systematic review of safety and efficacy","volume":"25","author":"Scheffer","year":"2014","journal-title":"J Vasc Interv Radiol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0039","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.ejso.2014.08.480","article-title":"Systematic review of irreversible electroporation in the treatment of advanced pancreatic cancer","volume":"40","author":"Moir","year":"2014","journal-title":"Eur J Surg Oncol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0040","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/bjs.9716","article-title":"Systematic review of innovative ablative therapies for the treatment of locally advanced pancreatic cancer","volume":"102","author":"Rombouts","year":"2015","journal-title":"Br J Surg"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0041","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1055\/s-0034-1373785","article-title":"The state of irreversible electroporation in interventional oncology","volume":"31","author":"Silk","year":"2014","journal-title":"Semin Interv Radiol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0042","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/s12885-016-2332-z","article-title":"Focal vs extended ablation in localized prostate cancer with irreversible electroporation; a multi-center randomized controlled trial","volume":"16","author":"Scheltema","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0043","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.jacep.2018.04.005","article-title":"Ablation of atrial fibrillation with pulsed electric fields: an ultra-rapid, tissue-selective modality for cardiac ablation","volume":"4","author":"Reddy","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0044","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.jacep.2018.06.005","article-title":"Electroporation and its relevance for cardiac catheter ablation","volume":"4","author":"Wittkampf","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0045","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejcsup.2006.08.006","article-title":"Importance of tumour coverage by sufficiently high local electric field for effective electrochemotherapy","volume":"4","author":"Miklavcic","year":"2006","journal-title":"Eur J Cancer Suppl"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0046","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejcsup.2006.08.005","article-title":"Bases and rationale of the electrochemotherapy","volume":"4","author":"Mir","year":"2006","journal-title":"Eur J Cancer Suppl"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0047","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1586\/era.10.43","article-title":"Antivascular effects of electrochemotherapy: implications in treatment of bleeding metastases","volume":"10","author":"Jarm","year":"2010","journal-title":"Exp Rev Anticancer Ther"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0048","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/sj.bjc.6604168","article-title":"Vascular disrupting action of electroporation and electrochemotherapy with bleomycin in murine sarcoma","volume":"98","author":"Sersa","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0049","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1158\/1535-7163.MCT-06-0410","article-title":"The endothelial cytoskeleton as a target of electroporation-based therapies","volume":"5","author":"Kanthou","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180709","article-title":"Histopathological findings in colorectal liver metastases after electrochemotherapy","volume":"12","author":"Gasljevic","year":"2017","journal-title":"PloS One"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0051","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/00008390-200012000-00011","article-title":"Efficient palliation of haemorrhaging malignant melanoma skin metastases by electrochemotherapy","volume":"10","author":"Gehl","year":"2000","journal-title":"Melanoma Res"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0052","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1177\/030089160909500324","article-title":"Limb sparing treatment of bleeding melanoma recurrence by electrochemotherapy","volume":"95","author":"Snoj","year":"2009","journal-title":"Tumori"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0053","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1084\/jem.192.4.565","article-title":"High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes","volume":"192","author":"Andersson","year":"2000","journal-title":"J Exp Med"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0054","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nature08296","article-title":"Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance","volume":"461","author":"Elliott","year":"2009","journal-title":"Nature"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0055","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nm1523","article-title":"Calreticulin exposure dictates the immunogenicity of cancer cell death","volume":"13","author":"Obeid","year":"2007","journal-title":"Nat Med"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0056","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nature00858","article-title":"Release of chromatin protein HMGB1 by necrotic cells triggers inflammation","volume":"418","author":"Scaffidi","year":"2002","journal-title":"Nature"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0057","doi-asserted-by":"crossref","first-page":"e28131","DOI":"10.4161\/onci.28131","article-title":"Electrochemotherapy with bleomycin induces hallmarks of immunogenic cell death in murine colon cancer cells","volume":"3","author":"Calvet","year":"2014","journal-title":"Oncoimmunol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0058","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s00262-015-1724-2","article-title":"Electrochemotherapy of tumors as in situ vaccination boosted by immunogene electrotransfer","volume":"64","author":"Sersa","year":"2015","journal-title":"Cancer Immunol Immunother"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0059","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/jid.2009.307","article-title":"Indoleamine 2,3-dioxygenase+ cells correspond to the BDCA2+ plasmacytoid dendritic cells in human melanoma sentinel nodes","volume":"130","author":"Gerlini","year":"2010","journal-title":"J Investig Dermatol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0060","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/S0002-9440(10)63238-5","article-title":"Metastatic melanoma secreted IL-10 down-regulates CD1 molecules on dendritic cells in metastatic tumor lesions","volume":"165","author":"Gerlini","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0061","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1515\/raon-2015-0005","article-title":"Adjuvant TNF-alpha therapy to electrochemotherapy with intravenous cisplatin in murine sarcoma exerts synergistic antitumor effectiveness","volume":"49","author":"Cemazar","year":"2015","journal-title":"Radiol Oncol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0062","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/00008390-200012000-00010","article-title":"In vivo electroporation of plasmids encoding GM-CSF or interleukin-2 into existing B16 melanomas combined with electrochemotherapy induces long-term antitumour immunity","volume":"10","author":"Heller","year":"2000","journal-title":"Melanoma Res"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0063","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10585-012-9505-1","article-title":"Dendritic cells recruitment in melanoma metastasis treated by electrochemotherapy","volume":"30","author":"Gerlini","year":"2013","journal-title":"Clin Exp Metastasis"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0064","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2147\/CCID.S115984","article-title":"Electrochemotherapy induces apoptotic death in melanoma metastases: a histologic and immunohistochemical investigation","volume":"9","author":"Bigi","year":"2016","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0065","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s10585-016-9814-x","article-title":"CD4(+)FOXP3(+) T regulatory cells decrease and CD3(+)CD8(+) T cells recruitment in TILs from melanoma metastases after electrochemotherapy","volume":"33","author":"Di Gennaro","year":"2016","journal-title":"Clin Exp Metastasis"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0066","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00262-016-1856-z","article-title":"Immune checkpoint blockade with concurrent electrochemotherapy in advanced melanoma: a retrospective multicenter analysis","volume":"65","author":"Heppt","year":"2016","journal-title":"Cancer Immunol Immunother"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0067","article-title":"Electrochemotherapy with anti-PD-1 treatment induced durable complete response in heavily pretreated metastatic melanoma patient","author":"Karaca","year":"2017","journal-title":"Anticancer Drugs"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0068","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1158\/2326-6066.CIR-15-0156","article-title":"Local tumor treatment in combination with systemic ipilimumab immunotherapy prolongs overall survival in patients with advanced malignant melanoma","volume":"4","author":"Theurich","year":"2016","journal-title":"Cancer Immunol Res"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0069","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1008842","article-title":"Assessing a novel immuno-oncology-based combination therapy: ipilimumab plus electrochemotherapy","volume":"4","author":"Mozzillo","year":"2015","journal-title":"Oncoimmunol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0070","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00001813-199804000-00005","article-title":"Enhancement of cytotoxicity by electropermeabilization: an improved method for screening drugs","volume":"9","author":"Gehl","year":"1998","journal-title":"Anticancer Drugs"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0071","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0305-7372(03)00073-2","article-title":"Electrochemotherapy: results of cancer treatment using enhanced delivery of bleomycin by electroporation","volume":"29","author":"Gothelf","year":"2003","journal-title":"Cancer Treat Rev"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0072","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/00001813-200003000-00008","article-title":"Toxicity of anticancer agents mediated by electroporation in vitro","volume":"11","author":"Jaroszeski","year":"2000","journal-title":"Anticancer Drugs"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0073","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.1016\/0006-2952(88)90344-9","article-title":"Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs","volume":"37","author":"Orlowski","year":"1988","journal-title":"Biochem Pharmacol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0074","first-page":"3450","article-title":"Antitumor effectiveness of electrochemotherapy with cis-diamminedichloroplatinum(II) in mice","volume":"55","author":"Sersa","year":"1995","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0075","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1038\/bjc.1998.388","article-title":"Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy","volume":"77","author":"Mir","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0076","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/0277-5379(91)90064-K","article-title":"Electrochemotherapy potentiation of antitumor effect of bleomycin by local electric pulses","volume":"27","author":"Mir","year":"1991","journal-title":"Eur J Cancer"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0077","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/0306-3623(95)02101-9","article-title":"Bleomycin: revival of an old drug","volume":"27","author":"Mir","year":"1996","journal-title":"Gen Pharmacol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0078","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1475-925X-13-29","article-title":"Electrochemotherapy: from the drawing board into medical practice","volume":"13","author":"Miklavcic","year":"2014","journal-title":"Biomed Eng Online"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0079","first-page":"200","article-title":"New antibiotics, bleomycin A and B","volume":"19","author":"Umezawa","year":"1966","journal-title":"J Antibiotics"},{"issue":"Suppl","key":"10.1053\/j.seminoncol.2019.04.002_bib0080","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/0006-2952(91)90394-K","article-title":"Very high cytotoxicity of bleomycin introduced into the cytosol of cells in culture","volume":"42","author":"Poddevin","year":"1991","journal-title":"Biochem Pharmacol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0081","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0006-2952(94)90101-5","article-title":"Involvement of membrane bleomycin-binding sites in bleomycin cytotoxicity","volume":"48","author":"Pron","year":"1994","journal-title":"Biochem Pharmacol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0082","first-page":"5462","article-title":"Bleomycin, an apoptosis-mimetic drug that induces two types of cell death depending on the number of molecules internalized","volume":"53","author":"Tounekti","year":"1993","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0083","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nrc1547","article-title":"Bleomycins: towards better therapeutics","volume":"5","author":"Chen","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0084","doi-asserted-by":"crossref","first-page":"945","DOI":"10.7326\/0003-4819-90-6-945","article-title":"Bleomycin","volume":"90","author":"Bennett","year":"1979","journal-title":"Ann Int Med"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0085","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1093\/nar\/gkn302","article-title":"Mechanistic studies on bleomycin-mediated DNA damage: multiple binding modes can result in double-stranded DNA cleavage","volume":"36","author":"Chen","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0086","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF02034932","article-title":"Mechanisms of bleomycin-induced lung damage","volume":"65","author":"Hay","year":"1991","journal-title":"Arch Toxicol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0087","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF00253118","article-title":"Bleomycin pharmacokinetics in man. I. Intravenous administration","volume":"1","author":"Alberts","year":"1978","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0088","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1073\/pnas.80.10.3064","article-title":"Lack of metabolism as the biochemical basis of bleomycin-induced pulmonary toxicity","volume":"80","author":"Lazo","year":"1983","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0089","first-page":"1299","article-title":"Bleomycin in dermatology: a review of intralesional applications","volume":"34","author":"Saitta","year":"2008","journal-title":"Dermatol Surg"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0090","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1080\/0284186X.2018.1454602","article-title":"Updated standard operating procedures for electrochemotherapy of cutaneous tumours and skin metastases","volume":"57","author":"Gehl","year":"2018","journal-title":"Acta Oncol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0091","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2310\/7750.2006.00037","article-title":"Randomized controlled study of electrochemotherapy in the local treatment of skin metastases of melanoma","volume":"10","author":"Gaudy","year":"2006","journal-title":"J Cutan Med Surg"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0092","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/hed.24991","article-title":"Efficiency of electrochemotherapy with reduced bleomycin dose in the treatment of nonmelanoma head and neck skin cancer: preliminary results","volume":"40","author":"Groselj","year":"2018","journal-title":"Head Neck"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0093","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s00280-016-3004-z","article-title":"Bleomycin pharmacokinetics of bolus bleomycin dose in elderly cancer patients treated with electrochemotherapy","volume":"77","author":"Groselj","year":"2016","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0094","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/jdv.14708","article-title":"Electrochemotherapy of unresectable cutaneous tumours with reduced dosages of intravenous bleomycin: analysis of 57 patients from the International Network for Sharing Practices of Electrochemotherapy registry","volume":"32","author":"Rotunno","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0095","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/bjs.8749","article-title":"Electrochemotherapy for disseminated superficial metastases from malignant melanoma","volume":"99","author":"Campana","year":"2012","journal-title":"Br J Surg"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0096","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1111\/bjd.15340","article-title":"Electrochemotherapy in the treatment of metastatic malignant melanoma: a prospective cohort study by InspECT","volume":"176","author":"Kunte","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0097","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1245\/s10434-008-9976-0","article-title":"Electrochemotherapy with intravenous bleomycin in the local treatment of skin melanoma metastases","volume":"15","author":"Quaglino","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0098","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/j.1365-2133.2006.07474.x","article-title":"Bleomycin and the skin","volume":"155","author":"Yamamoto","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0099","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.pupt.2005.01.007","article-title":"Bleomycin lung toxicity: who are the patients with increased risk?","volume":"18","author":"Azambuja","year":"2005","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0100","unstructured":"Bleomycin in: BC Cancer Agency Cancer Drug Manual. Retrieved from:http:\/\/www.bccancer.bc.ca\/drug-database-site\/Drug%20Index\/Bleomycin_monograph_1Dec2014.pdf."},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0101","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/205698a0","article-title":"Inhibition of cell division in escherichia coli by electrolysis products from a platinum electrode","volume":"205","author":"Rosenberg","year":"1965","journal-title":"Nature"},{"issue":"11","key":"10.1053\/j.seminoncol.2019.04.002_bib0102","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17111818","article-title":"Transition metal intercalators as anticancer agents-recent advances","volume":"17","author":"Deo","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0103","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/187152007779314044","article-title":"Biochemical mechanisms of cisplatin cytotoxicity","volume":"7","author":"Cepeda","year":"2007","journal-title":"Anticancer Agents Med Chem"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0104","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejmech.2017.04.007","article-title":"Platinum, palladium, gold and ruthenium complexes as anticancer agents: current clinical uses, cytotoxicity studies and future perspectives","volume":"142","author":"Lazarevic","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0105","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/21460","article-title":"Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins","volume":"399","author":"Ohndorf","year":"1999","journal-title":"Nature"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0106","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.3390\/cancers3011351","article-title":"Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effects","volume":"3","author":"Florea","year":"2011","journal-title":"Cancers"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0107","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/MAJ.0b013e31812dfe1e","article-title":"Cisplatin nephrotoxicity: a review","volume":"334","author":"Yao","year":"2007","journal-title":"Am J Med Sci"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0108","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/00001813-199807000-00002","article-title":"Intratumoral cisplatin administration in electrochemotherapy: antitumor effectiveness, sequence dependence and platinum content","volume":"9","author":"Cemazar","year":"1998","journal-title":"Anticancer Drugs"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0109","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S0959-8049(98)00025-2","article-title":"Electrochemotherapy with cisplatin: potentiation of local cisplatin antitumour effectiveness by application of electric pulses in cancer patients","volume":"34","author":"Sersa","year":"1998","journal-title":"Eur J Cancer"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0110","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.3390\/toxins2112490","article-title":"Mechanisms of Cisplatin nephrotoxicity","volume":"2","author":"Miller","year":"2010","journal-title":"Toxins"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0111","first-page":"2766","article-title":"Atopic hypersensitivity to cis-dichlorodiammineplatinum(II) and other platinum complexes","volume":"35","author":"Khan","year":"1975","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0112","first-page":"863","article-title":"Electrochemotherapy with cisplatin: clinical experience in malignant melanoma patients","volume":"6","author":"Sersa","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0113","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.bioelechem.2006.11.001","article-title":"Real time electroporation control for accurate and safe in vivo non-viral gene therapy","volume":"70","author":"Cukjati","year":"2007","journal-title":"Bioelectrochemistry"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0114","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1245\/s10434-008-0204-8","article-title":"Bleomycin-based electrochemotherapy: clinical outcome from a single institution's experience with 52 patients","volume":"16","author":"Campana","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0115","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s10549-012-2095-4","article-title":"The activity and safety of electrochemotherapy in persistent chest wall recurrence from breast cancer after mastectomy: a phase-II study","volume":"134","author":"Campana","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0116","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1515\/raon-2017-0027","article-title":"Electrochemotherapy \u2013 supplementary treatment for loco-regional metastasized breast carcinoma administered to concomitant systemic therapy","volume":"51","author":"Grischke","year":"2017","journal-title":"Radiol Oncol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0117","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3109\/0284186X.2014.992546","article-title":"Predicting patients at risk for pain associated with electrochemotherapy","volume":"54","author":"Quaglino","year":"2015","journal-title":"Acta Oncol"},{"issue":"1","key":"10.1053\/j.seminoncol.2019.04.002_bib0118","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12967-017-1225-5","article-title":"Basal cell carcinoma: 10-year experience with electrochemotherapy","volume":"15","author":"Campana","year":"2017","journal-title":"J Transl Med"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0119","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1007\/s00432-014-1691-6","article-title":"Bleomycin electrochemotherapy in elderly metastatic breast cancer patients: clinical outcome and management considerations","volume":"140","author":"Campana","year":"2014","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0120","doi-asserted-by":"crossref","first-page":"14","DOI":"10.5313\/wja.v2.i2.14","article-title":"Electrochemotherapy and heart function: treatment in a patient with implantable cardioverter defibrillator\/pacemaker","volume":"2","author":"Marandola M","year":"2013","journal-title":"World J Anesthesiol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0121","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ejca.2017.10.008","article-title":"European Research on Electrochemotherapy in Head and Neck Cancer (EURECA) project: results from the treatment of mucosal cancers","volume":"87","author":"Plaschke","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0122","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejca.2016.05.001","article-title":"European Research on Electrochemotherapy in Head and Neck Cancer (EURECA) project: results of the treatment of skin cancer","volume":"63","author":"Bertino","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0123","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.bjoms.2014.08.004","article-title":"Electrochemotherapy in non-melanoma head and neck cancers: a retrospective analysis of the treated cases","volume":"52","author":"Campana","year":"2014","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0124","doi-asserted-by":"crossref","first-page":"160","DOI":"10.4103\/0970-9185.182085","article-title":"Intravenous sub-anesthetic ketamine for perioperative analgesia","volume":"32","author":"Gorlin","year":"2016","journal-title":"J Anaesth Clin Pharmacol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0125","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/dsu.12190","article-title":"Electrochemotherapy under tumescent local anesthesia for the treatment of cutaneous metastases","volume":"39","author":"Kendler","year":"2013","journal-title":"Dermatol Surg"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0126","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3109\/0284186X.2011.573626","article-title":"Management of cutaneous metastases using electrochemotherapy","volume":"50","author":"Matthiessen","year":"2011","journal-title":"Acta Oncol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0127","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/(SICI)1097-0142(19980701)83:1<148::AID-CNCR20>3.0.CO;2-W","article-title":"Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin","volume":"83","author":"Heller","year":"1998","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0128","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ijsu.2018.02.040","article-title":"Patient reported outcomes in prospective cohort study of Electrochemotherapy","volume":"52","author":"Al-Hadithy","year":"2018","journal-title":"Int J Surg"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0129","series-title":"The royal marsden hospital handbook of wound management in cancer care","author":"Naylor","year":"2001"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0130","first-page":"242","article-title":"Algoritmo terapeutico per il trattamento delle metastasi del sacro. Raccomandazioni del Gruppo di Studio SIOT sulle metastasi ossee","volume":"42","author":"Capanna","year":"2016","journal-title":"Giornale Italiano di Ortopedia e Traumatologia"},{"issue":"6","key":"10.1053\/j.seminoncol.2019.04.002_bib0131","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13569-016-0060-4","article-title":"UK guidelines for the management of soft tissue sarcomas","volume":"15","author":"Dangoor","year":"2016","journal-title":"Clin Sarcoma Res"},{"issue":"Suppl 5","key":"10.1053\/j.seminoncol.2019.04.002_bib0132","doi-asserted-by":"crossref","first-page":"v126","DOI":"10.1093\/annonc\/mdv297","article-title":"Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"26","author":"Dummer","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0133","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ejca.2016.05.005","article-title":"Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline \u2013 Update 2016","volume":"63","author":"Garbe","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0134","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1016\/j.ejca.2012.06.013","article-title":"Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline \u2013 Update 2012","volume":"48","author":"Garbe","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0135","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1586\/14737140.2014.856532","article-title":"Italian Orthopaedic Society Bone Metastasis Study G: management of patients with metastasis to the vertebrae: recommendations from the Italian Orthopaedic Society (SIOT) Bone Metastasis Study Group","volume":"14","author":"Gasbarrini","year":"2014","journal-title":"Exp Rev Anticancer Ther"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0136","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000353590","article-title":"AGO recommendations for diagnosis and treatment of patients with advanced and metastatic breast cancer: update 2013","volume":"8","author":"Harbeck","year":"2013","journal-title":"Breast Care"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0137","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1016\/j.ejca.2015.06.131","article-title":"Diagnosis and treatment of merkel cell carcinoma. European consensus-based interdisciplinary guideline","volume":"51","author":"Lebbe","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0138","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1365-2133.2010.09883.x","article-title":"Revised U.K. guidelines for the management of cutaneous melanoma 2010","volume":"163","author":"Marsden","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0139","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/bjd.14104","article-title":"Management of cutaneous squamous cell carcinoma in patients with epidermolysis bullosa: best clinical practice guidelines","volume":"174","author":"Mellerio","year":"2016","journal-title":"Br J Dermatol"},{"issue":"Suppl 6","key":"10.1053\/j.seminoncol.2019.04.002_bib0140","first-page":"111","article-title":"Malignant melanoma S3-guideline \"diagnosis, therapy and follow-up of melanoma\"","volume":"11","author":"Pflugfelder","year":"2013","journal-title":"J German Soc Dermatol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0141","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/j.ejca.2015.06.110","article-title":"Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline","volume":"51","author":"Stratigos","year":"2015","journal-title":"Eur J Cancer"},{"issue":"Suppl 3","key":"10.1053\/j.seminoncol.2019.04.002_bib0142","doi-asserted-by":"crossref","first-page":"S442","DOI":"10.1245\/s10434-015-4779-6","article-title":"Electrochemotherapy in the treatment of cutaneous metastases from breast cancer: a multicenter cohort analysis","author":"Cabula","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0143","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1515\/raon-2016-0006","article-title":"Recommendations for improving the quality of reporting clinical electrochemotherapy studies based on qualitative systematic review","volume":"50","author":"Campana","year":"2016","journal-title":"Radiol Oncol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0144","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1053\/j.seminoncol.2016.02.031","article-title":"Cutaneous manifestations associated with melanoma","volume":"43","author":"Vyas","year":"2016","journal-title":"Semin Oncol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0145","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2478\/raon-2014-0035","article-title":"Consolidation electrochemotherapy with bleomycin in metastatic melanoma during treatment with dabrafenib","volume":"49","author":"Valpione","year":"2015","journal-title":"Radiol Oncol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0146","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/jso.23512","article-title":"Treatment of metastatic melanoma with electrochemotherapy","volume":"109","author":"Campana","year":"2014","journal-title":"J Surg Oncol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0147","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/(SICI)1097-0142(19960301)77:5<964::AID-CNCR24>3.0.CO;2-0","article-title":"Phase I\/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy","volume":"77","author":"Heller","year":"1996","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0148","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1186\/1471-2407-13-564","article-title":"Long-lasting response to electrochemotherapy in melanoma patients with cutaneous metastasis","volume":"13","author":"Caraco","year":"2013","journal-title":"BMC cancer"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0149","first-page":"816","article-title":"Electrochemotherapy of cutaneous metastases of melanoma\u2013a case series study and systematic review of the evidence","volume":"37","author":"Kis","year":"2011","journal-title":"Dermatol Surg"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0150","first-page":"285","article-title":"Electrochemotherapy in the treatment of melanoma skin metastases: a report on 31 cases","volume":"106","author":"Mir-Bonafe","year":"2015","journal-title":"Actas dermo-sifiliograficas"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0151","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/dth.12098","article-title":"Electrochemotherapy: an effective local treatment of cutaneous and subcutaneous melanoma metastases","volume":"27","author":"Ricotti","year":"2014","journal-title":"Dermatol Ther"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0152","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/1479-5876-10-131","article-title":"Use of neoadjuvant electrochemotherapy to treat a large metastatic lesion of the cheek in a patient with melanoma","volume":"10","author":"Mozzillo","year":"2012","journal-title":"J Transl Med"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0153","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/0190-9622(93)70173-Q","article-title":"Cutaneous metastases in patients with metastatic carcinoma: a retrospective study of 4020 patients","volume":"29","author":"Lookingbill","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0154","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1053\/j.seminoncol.2016.02.030","article-title":"Cutaneous manifestations of breast cancer","volume":"43","author":"Tan","year":"2016","journal-title":"Semin Oncol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0155","first-page":"167","article-title":"Cutaneous metastases from internal cancers","volume":"17","author":"Benmously","year":"2008","journal-title":"Acta dermatovenerol Alp Pannonica Adriat"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0156","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1200\/JCO.1999.17.1.101","article-title":"Local failure is responsible for the decrease in survival for patients with breast cancer treated with conservative surgery and postoperative radiotherapy","volume":"17","author":"Fortin","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0157","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S1053-4296(05)80097-9","article-title":"Natural history and management of isolated local-regional recurrence following mastectomy","volume":"4","author":"Bedwinek","year":"1994","journal-title":"Semin Radiat Oncol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0158","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1053\/ctrv.2000.0204","article-title":"Locoregionally recurrent breast cancer: incidence, risk factors and survival","volume":"27","author":"Clemons","year":"2001","journal-title":"Cancer Treatment Rev"},{"issue":"Suppl 1","key":"10.1053\/j.seminoncol.2019.04.002_bib0159","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1186\/1471-2482-12-S1-S6","article-title":"Electrochemotherapy of cutaneous metastastes from breast cancer in elderly patients: a preliminary report","volume":"12","author":"Benevento","year":"2012","journal-title":"BMC Surg"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0160","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10549-016-4046-y","article-title":"Effective treatment of intractable cutaneous metastases of breast cancer with electrochemotherapy: Ten-year audit of single centre experience","volume":"161","author":"Bourke","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0161","doi-asserted-by":"crossref","first-page":"713","DOI":"10.3109\/0284186X.2012.685524","article-title":"Electrochemotherapy for large cutaneous recurrence of breast cancer: a phase II clinical trial","volume":"51","author":"Matthiessen","year":"2012","journal-title":"Acta Oncol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0162","doi-asserted-by":"crossref","first-page":"e909","DOI":"10.1016\/j.clbc.2018.03.007","article-title":"Electrochemotherapy for breast cancer-results from the INSPECT database","volume":"18","author":"Matthiessen","year":"2018","journal-title":"Clin Breast Cancer"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0163","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2478\/raon-2013-0002","article-title":"Tumor size and effectiveness of electrochemotherapy","volume":"47","author":"Mali","year":"2013","journal-title":"Radiol Oncol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0164","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1093\/annonc\/mdt303","article-title":"Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013","volume":"24","author":"Goldhirsch","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0165","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10549-017-4187-7","article-title":"Effective treatment of intractable cutaneous metastases of breast cancer with electrochemotherapy: a useful contributor to cutaneous disease control","volume":"163","author":"Bourke","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0166","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s10549-017-4186-8","article-title":"Treatment of cutaneous metastases of breast cancer with electrochemotherapy: what is the magnitude of clinical benefit?","volume":"163","author":"Campana","year":"2017","journal-title":"Br Cancer Res Treat"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0167","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/00005537-200101000-00010","article-title":"Electroporation therapy for head and neck cancer including carotid artery involvement","volume":"111","author":"Allegretti","year":"2001","journal-title":"Laryngoscope"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0168","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.ejso.2005.04.007","article-title":"The role of intratumour therapy with electroporation and bleomycin in the management of advanced squamous cell carcinoma of the head and neck","volume":"31","author":"Bloom","year":"2005","journal-title":"Eur J Surg Oncol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0169","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1080\/00016480310001114","article-title":"Electroporation therapy in head and neck cancer","volume":"123","author":"Burian","year":"2003","journal-title":"Acta Otolaryngol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0170","first-page":"1185","article-title":"Electrochemotherapy in combination with chemoradiotherapy in the treatment of oral carcinomas in advanced stages of disease: efficacy, safety, and clinical outcomes in a small number of selected cases","volume":"9","author":"Domanico","year":"2015","journal-title":"Drug Des Devel Ther"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0171","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1002\/(SICI)1097-0142(19960301)77:5<956::AID-CNCR23>3.0.CO;2-1","article-title":"Antitumor electrochemotherapy: new advances in the clinical protocol","volume":"77","author":"Domenge","year":"1996","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0172","first-page":"32","article-title":"A relapsed lower-lip squamous cell carcinoma treated with curative electrochemotherapy in an elderly patient","volume":"67","author":"Gargiulo","year":"2018","journal-title":"Minerva Stomatol"},{"issue":"6","key":"10.1053\/j.seminoncol.2019.04.002_bib0173","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1097\/SLA.0b013e31824f68b2","article-title":"Electrochemotherapy for non-melanoma head and neck cancers: clinical outcomes in 25 patients","volume":"255","author":"Gargiulo","year":"2012","journal-title":"Ann Surg"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0174","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.3109\/00016489.2015.1049663","article-title":"Long-term follow-up in patients treated with curative electrochemotherapy for cancer in the oral cavity and oropharynx","volume":"135","author":"Landstrom","year":"2015","journal-title":"Acta Otolaryngol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0175","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3109\/00016489.2014.947655","article-title":"Electrochemotherapy \u2013 possible benefits and limitations to its use in the head and neck region","volume":"135","author":"Landstrom","year":"2015","journal-title":"Acta Otolaryngol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0176","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1177\/030089161209800305","article-title":"Electrochemotherapy for the treatment of recurrent head and neck cancers: preliminary results","volume":"98","author":"Mevio","year":"2012","journal-title":"Tumori"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0177","first-page":"19","article-title":"Electrochemotherapy for basocellular and squamocellular head and neck cancer: preliminary experience in Day Surgery Unit","volume":"153","author":"Montuori","year":"2018","journal-title":"G Ital Dermatol Venereol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0178","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1177\/000348949810700908","article-title":"Electroporation therapy of head and neck cancer","volume":"107","author":"Panje","year":"1998","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0179","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2500\/105065800782102744","article-title":"Endoscopic and electroporation therapy of paranasal sinus tumors","volume":"14","author":"Panje","year":"2000","journal-title":"Am J Rhinol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0180","doi-asserted-by":"crossref","first-page":"181","DOI":"10.14639\/0392-100X-1262","article-title":"Electrochemotherapy: a well-accepted palliative treatment by patients with head and neck tumours","volume":"38","author":"Pichi","year":"2018","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0181","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/hed.25454","article-title":"The DAHANCA 32 study: electrochemotherapy for recurrent, mucosal head and neck cancer","volume":"41","author":"Plaschke CC","year":"2019","journal-title":"Head Neck"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0182","first-page":"610","article-title":"Electrochemotherapy in non-melanoma head and neck skin cancers: a three-center experience and review of the literature","volume":"151","author":"Rotunno","year":"2016","journal-title":"G Ital Dermatol Venereol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0183","first-page":"967","article-title":"Electrochemotherapy and its controversial results in patients with head and neck cancer","volume":"34","author":"Seccia","year":"2014","journal-title":"Anticancer Res"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0184","first-page":"265","article-title":"Electrochemotherapy in cancer patients: first clinical trial in Greece","volume":"25","author":"Skarlatos","year":"2011","journal-title":"In Vivo"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0185","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1749-4486.2006.01198.x","article-title":"How we do it: Chemo-electroporation in the head and neck for otherwise untreatable patients","volume":"31","author":"Tijink","year":"2006","journal-title":"Clin Otolaryngol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0186","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1056\/NEJMoa0802656","article-title":"Platinum-based chemotherapy plus cetuximab in head and neck cancer","volume":"359","author":"Vermorken","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0187","doi-asserted-by":"crossref","first-page":"E86","DOI":"10.1002\/hed.23552","article-title":"Use of electrochemotherapy in a case of neck skin metastasis of oral squamous cell carcinoma: case report and considerations","volume":"36","author":"Macri","year":"2014","journal-title":"Head Neck"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0188","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcms.2018.08.013","article-title":"Long term effectiveness of electrochemotherapy for the treatment of lower lip squamous cell carcinoma","author":"Gargiulo","year":"2018","journal-title":"J Craniomaxillofac Surg"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0189","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1007\/s00405-017-4490-2","article-title":"The controversial role of electrochemotherapy in head and neck cancer: a systematic review of the literature","volume":"274","author":"Lenzi","year":"2017","journal-title":"Eur Arch Oto-Rhinolaryngol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0190","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ejso.2013.11.013","article-title":"The value of electrochemotherapy in the treatment of peristomal tumors","volume":"40","author":"Campana","year":"2014","journal-title":"Eur J Surgl Oncol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0191","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.bjorl.2015.05.008","article-title":"Electrochemotherapy as palliative treatment in patients with thyroid papillary carcinoma","volume":"82","author":"Grau","year":"2016","journal-title":"Braz J Otorhinolaryngol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0192","first-page":"132","article-title":"Electrochemotherapy: a valid treatment for Gorlin-Goltz syndrome","volume":"21","author":"Curatolo","year":"2013","journal-title":"Acta Dermatovenerol Croat"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0193","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1001\/archderm.144.9.1186","article-title":"Metastatic basal cell carcinoma with squamous differentiation: report of a case with response of cutaneous metastases to electrochemotherapy","volume":"144","author":"Fantini","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0194","doi-asserted-by":"crossref","first-page":"378","DOI":"10.4103\/0378-6323.136989","article-title":"Electrochemotherapy for a locally advanced basal cell carcinoma on the forehead","volume":"80","author":"Gatti","year":"2014","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0195","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0190-9622(96)90838-5","article-title":"Bleomycin-mediated electrochemotherapy of basal cell carcinoma","volume":"34","author":"Glass","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0196","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0190-9622(97)70178-6","article-title":"Intralesional bleomycin-mediated electrochemotherapy in 20 patients with basal cell carcinoma","volume":"37","author":"Glass","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0197","doi-asserted-by":"crossref","first-page":"648","DOI":"10.2340\/00015555-1361","article-title":"Successful treatment of multiple basaliomas with bleomycin-based electrochemotherapy: a case series of three patients with Gorlin-Goltz syndrome","volume":"92","author":"Kis","year":"2012","journal-title":"Acta Derm Venereol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0198","first-page":"443","article-title":"Efficacy of electrochemotherapy in ulcerated basal cell carcinoma","volume":"162","author":"Richetta","year":"2011","journal-title":"Clin Ter"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0199","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.bjps.2013.07.019","article-title":"Electrochemotherapy for the treatment of ocular basal cell carcinoma; a novel adjunct in the disease management","volume":"67","author":"Salwa","year":"2014","journal-title":"J Plast Reconstr Aesth Surg"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0200","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/jso.23481","article-title":"Electrochemotherapy for the management of cutaneous and subcutaneous metastasis: a series of 39 patients treated with palliative intent","volume":"109","author":"Solari","year":"2014","journal-title":"J Surg Oncol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0201","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12967-017-1186-8","article-title":"Electrochemotherapy efficacy evaluation for treatment of locally advanced stage III cutaneous squamous cell carcinoma: a 22-cases retrospective analysis","volume":"15","author":"Di Monta","year":"2017","journal-title":"J Transl Med"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0202","first-page":"308","article-title":"Electrochemotherapy in advanced skin tumors and cutaneous metastases \u2013 a retrospective multicenter analysis","volume":"13","author":"Kreuter","year":"2015","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0203","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1177\/030089161109700219","article-title":"Squamous cell carcinoma of the umbilicus: management of an unusual localization","volume":"97","author":"Macripo","year":"2011","journal-title":"Tumori"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0204","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1001\/archdermatol.2009.25","article-title":"Remission of extensive merkel cell carcinoma after electrochemotherapy","volume":"145","author":"Curatolo","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0205","first-page":"310","article-title":"Complete remission of Merkel cell carcinoma treated with electrochemotherapy and etoposide","volume":"148","author":"Curatolo","year":"2013","journal-title":"G Ital Dermatol Venereol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0206","doi-asserted-by":"crossref","first-page":"366","DOI":"10.2478\/raon-2013-0059","article-title":"Electrochemotherapy as a new therapeutic strategy in advanced Merkel cell carcinoma of head and neck region","volume":"47","author":"Scelsi","year":"2013","journal-title":"Radiol Oncol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0207","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1515\/raon-2016-0039","article-title":"Metastatic sebaceous cell carcinoma, review of the literature and use of electrochemotherapy as possible new treatment modality","volume":"50","author":"Ribero","year":"2016","journal-title":"Radiol Oncol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0208","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/dth.12374","article-title":"Efficacy of electrochemotherapy for eruptive legs keratoacanthomas","volume":"29","author":"Ribero","year":"2016","journal-title":"Dermatol Ther"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0209","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0188-4409(01)00278-8","article-title":"Electrochemotherapy in primary and metastatic skin tumors: phase II trial using intralesional bleomycin","volume":"32","author":"Rodriguez-Cuevas","year":"2001","journal-title":"Arch Med Res"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0210","first-page":"57","article-title":"Electrochemotherapy in the treatment of skin cancer","volume":"33","author":"Ferrandiz","year":"2018","journal-title":"Piel"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0211","series-title":"Poster, presented at the American association of plastic surgeons and plastic surgery research council joint meeting","article-title":"Prospective randomised controlled trial comparing electrochemotherapy and surgery for the primary treatment of basal cell carcinoma","author":"Tevlin RSS","year":"2016"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0212","first-page":"6121","article-title":"Electrochemotherapy of a multirecurrent dermatofibrosarcoma protuberans of the orbital margin: a case report","volume":"35","author":"Bonadies","year":"2015","journal-title":"Anticancer Res"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0213","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s00268-013-2321-1","article-title":"Electrochemotherapy treatment of locally advanced and metastatic soft tissue sarcomas: results of a non-comparative phase II study","volume":"38","author":"Campana","year":"2014","journal-title":"World J Surg"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0214","first-page":"839","article-title":"Successful treatment of penile Kaposi's sarcoma with electrochemotherapy","volume":"34","author":"Curatolo","year":"2008","journal-title":"Dermatol Surg"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0215","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1245\/s10434-011-1860-7","article-title":"Electrochemotherapy in the treatment of Kaposi sarcoma cutaneous lesions: a two-center prospective phase II trial","volume":"19","author":"Curatolo","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0216","doi-asserted-by":"crossref","first-page":"85234","DOI":"10.1155\/SRCM\/2006\/85234","article-title":"Electroporation therapy in soft tissue sarcoma: a potentially effective novel treatment","volume":"2006","author":"de Bree","year":"2006","journal-title":"Sarcoma"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0217","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejso.2013.09.002","article-title":"Electrochemotherapy as \"new standard of care\" treatment for cutaneous Kaposi's sarcoma","volume":"40","author":"Di Monta","year":"2014","journal-title":"Eur J Surg Oncol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0218","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1468-3083.2009.03395.x","article-title":"Electrochemotherapy-induced virus disappearance in HHV-8-positive skin nodules of Kaposi sarcoma: first histological and immunohistochemical demonstration of efficacy","volume":"24","author":"Gualdi","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0219","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/jso.24287","article-title":"Local treatment with electrochemotherapy of superficial angiosarcomas: efficacy and safety results from a multi-institutional retrospective study","volume":"114","author":"Guida","year":"2016","journal-title":"J Surg Oncol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0220","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1111\/bjd.15717","article-title":"Image Gallery: A case of cutaneous giant angiosarcoma treated successfully with electrochemotherapy","volume":"177","author":"Guida","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0221","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1529-8019.2012.01437.x","article-title":"Effective treatment of Kaposi's sarcoma by electrochemotherapy and intravenous bleomycin administration","volume":"25","author":"Latini","year":"2012","journal-title":"Dermatol Ther"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0222","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13027-017-0147-4","article-title":"Effect of electrochemotherapy on human herpesvirus 8 kinetics in classic Kaposi sarcoma","volume":"12","author":"Starita","year":"2017","journal-title":"Infect Agent Cancer"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0223","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jvir.2015.11.060","article-title":"Angiosarcoma on lymphedema (stewart-treves syndrome): a 12-year follow-up after isolated limb perfusion, limb infusion, and electrochemotherapy","volume":"27","author":"Campana","year":"2016","journal-title":"J Vasc Interv Radiol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0224","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s007760300043","article-title":"Electrochemotherapy for digital chondrosarcoma","volume":"8","author":"Shimizu","year":"2003","journal-title":"J Orthop Sci"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00432-008-0432-0","article-title":"Cutaneous metastases of visceral tumours: a review","volume":"135","author":"Nashan","year":"2009","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0226","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.det.2007.08.004","article-title":"Tumor invasion of the skin","volume":"26","author":"Rolz-Cruz","year":"2008","journal-title":"Dermatol Clin"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0227","doi-asserted-by":"crossref","first-page":"499","DOI":"10.4103\/1947-2714.118918","article-title":"The presentation, pathology, and current management strategies of cutaneous metastasis","volume":"5","author":"Wong","year":"2013","journal-title":"N Am J Med Sci"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0228","doi-asserted-by":"crossref","first-page":"370","DOI":"10.2478\/raon-2013-0051","article-title":"Minimally invasive treatment of peristomal metastases from gastric cancer at an ileostomy site by electrochemotherapy","volume":"47","author":"Campana","year":"2013","journal-title":"Radiol Oncol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0229","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/030089160008600211","article-title":"Electrochemotherapy with bleomycin in the treatment of hypernephroma metastasis: case report and literature review","volume":"86","author":"Sersa","year":"2000","journal-title":"Tumori"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0230","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/dth.12128","article-title":"Electrochemotherapy as a novel treatment for primary cutaneous marginal zone B-cell lymphomas","volume":"27","author":"Gatti","year":"2014","journal-title":"Dermatol Ther"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0231","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.bioelechem.2006.10.006","article-title":"Electrochemotherapy of Mycosis fungoides by interferon-alpha","volume":"70","author":"Peycheva","year":"2007","journal-title":"Bioelectrochemistry"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0232","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ctrv.2009.01.005","article-title":"The management of vulval cancer","volume":"35","author":"Crosbie","year":"2009","journal-title":"Cancer Treat Rev"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0233","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.critrevonc.2006.02.008","article-title":"Surgery and radiotherapy in vulvar cancer","volume":"60","author":"de Hullu","year":"2006","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0234","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00001703-199901000-00011","article-title":"Radical resection of vulvar malignancies: a paradigm shift in surgical approaches","volume":"11","author":"Hacker","year":"1999","journal-title":"Curr Opin Obst Gynecol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0235","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003752.pub2","article-title":"Neoadjuvant chemoradiation for advanced primary vulvar cancer","volume":"3","author":"van Doorn","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0236","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1006\/gyno.1997.4659","article-title":"Effects of electrochemotherapy on CaSki cells derived from a cervical squamous cell carcinoma","volume":"65","author":"Yabushita","year":"1997","journal-title":"Gynecol Oncol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0237","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.ygyno.2013.06.028","article-title":"Electrochemotherapy can be used as palliative treatment in patients with repeated loco-regional recurrence of squamous vulvar cancer: a preliminary study","volume":"130","author":"Perrone","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0238","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/jso.24036","article-title":"Palliative electro-chemotherapy in elderly patients with vulvar cancer: a phase II trial","volume":"112","author":"Perrone","year":"2015","journal-title":"J Surg Oncol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0239","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3109\/0284186X.2015.1117134","article-title":"Outcomes of Bleomycin-based electrochemotherapy in patients with repeated loco-regional recurrences of vulvar cancer","volume":"55","author":"Pellegrino","year":"2016","journal-title":"Acta Oncol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0240","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1002\/jso.25072","article-title":"Electrochemotherapy pre-treatment in primary squamous vulvar cancer. Our preliminary experience","volume":"117","author":"Perrone","year":"2018","journal-title":"J Surg Oncol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0241","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.trsl.2011.11.007","article-title":"Keloids: what do we know and what do we do next?","volume":"159","author":"Blit","year":"2012","journal-title":"Transl Res"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0242","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.bjoms.2017.10.002","article-title":"Bleomycin electrosclerotherapy: new treatment to manage vascular malformations","volume":"55","author":"McMorrow","year":"2017","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0243","doi-asserted-by":"crossref","first-page":"e733","DOI":"10.1016\/j.bjps.2010.05.008","article-title":"Electrochemotherapy treatment of a recalcitrant earlobe keloid scar with chronic lymphocytic leukaemia infiltration","volume":"63","author":"Sainsbury","year":"2010","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0244","doi-asserted-by":"crossref","first-page":"621e","DOI":"10.1097\/PRS.0b013e3182a053c8","article-title":"Treatment of keloids and hypertrophic scars with bleomycin and electroporation","volume":"132","author":"Manca","year":"2013","journal-title":"Plastic Reconstruct Surg"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0245","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-016401","article-title":"Electrosclerotherapy for capillary malformations: study protocol for a randomised within-patient controlled pilot trial","volume":"7","author":"Horbach","year":"2017","journal-title":"BMJ open"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0246","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.2217\/fon-2017-0150","article-title":"Should we be combining local tumor therapies with immunotherapies as standard?","volume":"13","author":"Baues","year":"2017","journal-title":"Fut Oncol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0247","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1053\/j.seminoncol.2016.02.032","article-title":"Partnering with skin to outsmart cancer: following leads provided by tumor-specific T cells","volume":"43","author":"Edelson","year":"2016","journal-title":"Semin Oncol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0248","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.mayocp.2015.10.025","article-title":"Recurrence and survival outcomes after percutaneous thermal ablation of oligometastatic melanoma","volume":"91","author":"White","year":"2016","journal-title":"Mayo Clin Proc"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0249","series-title":"Handbook of electroporation","article-title":"Electrochemotherapy for superficially metastatic melanoma","author":"Campana","year":"2016"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0250","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/jso.23559","article-title":"Local and regional therapies for melanoma: many arrows in the quiver","volume":"109","author":"Thompson","year":"2014","journal-title":"J Surg Oncol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0251","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1684\/ejd.2015.2522","article-title":"Complete regression of melanoma skin metastases after electrochemotherapy plus ipilimumab treatment: an unusual clinical presentation","volume":"25","author":"Brizio","year":"2015","journal-title":"Eur J Dermatol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0252","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1093\/annonc\/mdy192","article-title":"4th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 4)","volume":"29","author":"Cardoso","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0253","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.critrevonc.2018.01.005","article-title":"Immunotherapy, an evolving approach for the management of triple negative breast cancer: converting non-responders to responders","volume":"122","author":"Tolba","year":"2018","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0254","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1245\/s10434-018-6620-5","article-title":"Immunotherapy for breast cancer is finally at the doorstep: immunotherapy in breast cancer","volume":"25","author":"De La Cruz","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0255","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S1470-2045(15)00054-6","article-title":"Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial","volume":"16","author":"Golden","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0256","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s12609-017-0234-y","article-title":"The abscopal effect of radiation therapy: what is it and how can we use it in breast cancer?","volume":"9","author":"Hu","year":"2017","journal-title":"Curr Breast Cancer Rep"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0257","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/jamaoncol.2016.6007","article-title":"Topical imiquimod plus nab-paclitaxel for breast cancer cutaneous metastases: a phase 2 clinical trial","volume":"3","author":"Salazar","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0258","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1365-4632.2012.05635.x","article-title":"Patterns of skin metastases: a review of 25 years' experience at a single cancer center","volume":"53","author":"Wong","year":"2014","journal-title":"Int J Dermatol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0259","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1053\/j.seminoncol.2016.02.023","article-title":"Cutaneous manifestations associated with malignancy of the head and neck","volume":"43","author":"Lorimer","year":"2016","journal-title":"Semin Oncol"},{"issue":"Suppl 3","key":"10.1053\/j.seminoncol.2019.04.002_bib0260","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/1475-925X-14-S3-S2","article-title":"Coupling treatment planning with navigation system: a new technological approach in treatment of head and neck tumors by electrochemotherapy","volume":"14","author":"Groselj","year":"2015","journal-title":"Biomed Eng Online"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0261","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1053\/j.seminoncol.2016.02.026","article-title":"Soft tissue sarcomas in skin: presentations and management","volume":"43","author":"Patt","year":"2016","journal-title":"Semin Oncol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0262","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1007\/s11517-012-0991-8","article-title":"Electrochemotherapy: technological advancements for efficient electroporation-based treatment of internal tumors","volume":"50","author":"Miklavcic","year":"2012","journal-title":"Med Biol Eng Comput"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0263","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1475-925X-9-10","article-title":"Towards treatment planning and treatment of deep-seated solid tumors by electrochemotherapy","volume":"9","author":"Miklavcic","year":"2010","journal-title":"Biomed Eng Online"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0264","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.4161\/onci.21991","article-title":"Enhancing anti-melanoma immunity by electrochemotherapy and in vivo dendritic-cell activation","volume":"1","author":"Gerlini","year":"2012","journal-title":"Oncoimmunol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0265","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1080\/0284186X.2017.1290274","article-title":"Electrochemotherapy and calcium electroporation inducing a systemic immune response with local and distant remission of tumors in a patient with malignant melanoma - a case report","volume":"56","author":"Falk","year":"2017","journal-title":"Acta Oncol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0266","first-page":"510","article-title":"Local tumour ablative therapies: opportunities for maximising immune engagement and activation","volume":"1846","author":"O'Brien","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0267","series-title":"Handbook of electroporation","article-title":"International Network for Sharing Practices on Electrochemotherapy (InspECT): an integrative patients treatment consortium","author":"Brizio M","year":"2016"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0268","series-title":"The Cancer atlas","year":"2014"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0269","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2147\/TCRM.S2780","article-title":"Cost-effectiveness analysis of electrochemotherapy with the Cliniporatortrade mark vs other methods for the control and treatment of cutaneous and subcutaneous tumors","volume":"4","author":"Colombo","year":"2008","journal-title":"Ther Clin Risk Manag"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0270","first-page":"22","article-title":"Study design of a medical device pre-market assessment: a case study on electrochemnotherapy","volume":"87","author":"Pirc E","year":"2018","journal-title":"Zdrav Vestn"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0271","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/jso.23625","article-title":"Intraoperative electrochemotherapy of colorectal liver metastases","volume":"110","author":"Edhemovic","year":"2014","journal-title":"J Surg Oncol"},{"key":"10.1053\/j.seminoncol.2019.04.002_bib0272","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1016\/S1470-2045(11)70155-3","article-title":"Regulatory T cells in melanoma: the final hurdle towards effective immunotherapy?","volume":"13","author":"Jacobs","year":"2012","journal-title":"Lancet Oncol"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775418301945?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775418301945?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T12:55:31Z","timestamp":1758804931000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775418301945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":272,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0093775418301945"],"URL":"https:\/\/doi.org\/10.1053\/j.seminoncol.2019.04.002","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Electrochemotherapy of superficial tumors \u2013 Current status:","name":"articletitle","label":"Article Title"},{"value":"Seminars in Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminoncol.2019.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}